// AST – IMS - [DMinute_ROS]

Capital Advisors Has Cut Its Pfizer (PFE) Position by $525,976; Share Value Rose; Alphamark Advisors Has Lifted Position in Marriott Intl Cl A (MAR) by $3.90 Million

Marriott International, Inc. (NASDAQ:MAR) Logo

Capital Advisors Inc decreased its stake in Pfizer Inc (PFE) by 2.9% based on its latest 2018Q3 regulatory filing with the SEC. Capital Advisors Inc sold 11,954 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 399,592 shares of the health care company at the end of 2018Q3, valued at $17.61M, down from 411,546 at the end of the previous reported quarter. Capital Advisors Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $244.57B market cap company. The stock decreased 1.33% or $0.57 during the last trading session, reaching $42.31. About 5.62 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since January 14, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 03/04/2018 – Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price; 21/05/2018 – KARO PHARMA RECEIVES MILESTONE PAYMENT FOR RORGAMMA PROJECT FROM PFIZER; 29/05/2018 – PFIZER’S XALKORI® (CRIZOTINIB) GETS BREAKTHROUGH DESIGNATION IN; 26/03/2018 – Roche’s Tecentriq Improves Lung Cancer Treatment Results With Avastin; 26/04/2018 – ROCHE HOLDING AG ROG.S SAYS TECENTRIQ SALES 139 MLN SFR VS RTRS POLL AVG 154 MLN SFR; 23/03/2018 – STAT Plus: Pharmalittle: Glaxo drops out of bidding for Pfizer consumer unit; Trump policy could hike prices for biosimilars; 17/05/2018 – PFIZER: LYRICA MET PRIMARY ENDPOINT IN PEDIATRIC EPILEPSY TRIAL; 11/05/2018 – Eliquis (Apixaban; Bristol-Myers Squibb/Pfizer) Drug Overview 2017/18-2026: An Orally Available Factor Xa Inhibitor lndicated for the Prevention of Venous Thromboembolsim – ResearchAndMarkets.com; 06/03/2018 – Pfizer: Stephen Sanger to Retire From Board at Holder Meeting in April; 17/05/2018 – Roche Announces Positive Results From Phase III Trial on Tecentriq, Avastin and Two Drugs

Alphamark Advisors Llc increased its stake in Marriott Intl Inc Cl A (MAR) by 6927.7% based on its latest 2018Q3 regulatory filing with the SEC. Alphamark Advisors Llc bought 29,512 shares as the company’s stock declined 13.21% with the market. The institutional investor held 29,938 shares of the hotels and resorts company at the end of 2018Q3, valued at $3.95M, up from 426 at the end of the previous reported quarter. Alphamark Advisors Llc who had been investing in Marriott Intl Inc Cl A for a number of months, seems to be bullish on the $36.90 billion market cap company. The stock decreased 1.14% or $1.25 during the last trading session, reaching $108.17. About 370,693 shares traded. Marriott International, Inc. (NASDAQ:MAR) has declined 13.33% since January 14, 2018 and is downtrending. It has underperformed by 13.33% the S&P500. Some Historical MAR News: 16/05/2018 – Marriott Moments Introduces Expert Recommendations, Bespoke Categories, And Hand-Curated Activity Lists In Time For Summer Travel Season; 06/03/2018 – Sara Fischer: Exclusive: Marriott is moving its entire paid media business to Publicis; 17/04/2018 – St. Croix Source: Marriott Ownership Resorts (St.Thomas), Inc., Plaintiff, vs. James R. Davis and The Frenchman’s Cove; 09/05/2018 – MARRIOTT CEO SAYS QUITE OPTIMISTIC THAT HOME SHARING IN LONDON WILL GO WELL, IF IT DOES, WILL LOOK AT EXTENDING THAT TO OTHER CITIES – CONF CALL; 26/03/2018 – BGC PARTNERS – CONTRACT IS FOR CORPORATELY-MANAGED SITES OF MARRIOTT INTERNATIONAL INC THROUGHOUT UNITED STATES, CANADA AND MEXICO; 17/05/2018 – Marriott International: Unit Sells Montreal Hotel to Private Investor; 17/04/2018 – Marcus® Hotels & Resorts Assumes Management of the DoubleTree by Hilton Hotel El Paso Downtown and Courtyard by Marriott El Paso Downtown/Convention Center; 08/05/2018 – Marriott Sees FY EPS $5.43-EPS $5.55; 04/04/2018 – MARRIOTT INTERNATIONAL FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SERIES X NOTES DUE 2028 OFFERING OF UPTO $450 MLN – SEC FILING; 16/03/2018 – NY Warn Notices: 3 / 16 / 2018 – Courtyard by Marriott LaGuardia Hotel – New York City Region

Among 24 analysts covering Marriott International (NASDAQ:MAR), 13 have Buy rating, 0 Sell and 11 Hold. Therefore 54% are positive. Marriott International had 79 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Thursday, November 8 by Morgan Stanley. The company was upgraded on Sunday, May 20 by Evercore. The firm has “Market Perform” rating by Telsey Advisory Group given on Friday, September 23. Robert W. Baird maintained Marriott International, Inc. (NASDAQ:MAR) rating on Friday, November 10. Robert W. Baird has “Neutral” rating and $115 target. The firm has “Buy” rating by Canaccord Genuity given on Friday, December 4. RBC Capital Markets maintained the shares of MAR in report on Monday, August 7 with “Buy” rating. The rating was downgraded by SunTrust on Tuesday, February 21 to “Hold”. Barclays Capital downgraded Marriott International, Inc. (NASDAQ:MAR) on Wednesday, August 12 to “Overweight” rating. Goldman Sachs initiated the stock with “Buy” rating in Monday, September 26 report. RBC Capital Markets maintained the stock with “Buy” rating in Friday, September 22 report.

Alphamark Advisors Llc, which manages about $314.05 million and $248.23M US Long portfolio, decreased its stake in Advisorshs Ranger Eqy (HDGE) by 46,904 shares to 90,808 shares, valued at $668,000 in 2018Q3, according to the filing. It also reduced its holding in Health Insurance Innov (NASDAQ:HIIQ) by 15,980 shares in the quarter, leaving it with 17,620 shares, and cut its stake in Biotelemetry Inc (NASDAQ:BEAT).

More notable recent Marriott International, Inc. (NASDAQ:MAR) news were published by: Nasdaq.com which released: “Why Marriott Stock Jumped Today – Nasdaq” on January 04, 2019, also Globenewswire.com with their article: “MAR INVESTOR ALERT: Rosen Law Firm Reminds Marriott International, Inc. Investors of Important Deadline in First Class Action – MAR – GlobeNewswire” published on December 18, 2018, Nasdaq.com published: “ETFs in Focus on China Rate Cut – Nasdaq” on January 09, 2019. More interesting news about Marriott International, Inc. (NASDAQ:MAR) were released by: Nasdaq.com and their article: “H&R Block’s Investments to Reap Benefits, Costs May Mar Profit – Nasdaq” published on January 10, 2019 as well as Benzinga.com‘s news article titled: “Amazon.com, Inc. (NASDAQ:AMZN), Facebook, Inc. (NASDAQ:FB) – A Brewing Data Scandal Is The Last Thing Amazon Needs – Benzinga” with publication date: December 27, 2018.

Investors sentiment decreased to 0.72 in Q3 2018. Its down 0.30, from 1.02 in 2018Q2. It turned negative, as 63 investors sold MAR shares while 260 reduced holdings. 64 funds opened positions while 170 raised stakes. 209.52 million shares or 1.19% more from 207.07 million shares in 2018Q2 were reported. Great West Life Assurance Com Can invested 0.07% of its portfolio in Marriott International, Inc. (NASDAQ:MAR). Greenleaf Tru holds 0.01% or 2,629 shares in its portfolio. Gilman Hill Asset Mngmt Ltd Llc holds 0.24% of its portfolio in Marriott International, Inc. (NASDAQ:MAR) for 4,634 shares. Texas Permanent School Fund holds 0.12% or 64,653 shares in its portfolio. Trustmark Bank Department holds 0% or 96 shares. Gateway Investment Advisers Limited Com holds 0.05% of its portfolio in Marriott International, Inc. (NASDAQ:MAR) for 46,933 shares. State Of New Jersey Common Pension Fund D holds 134,000 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh holds 0.21% or 26,795 shares in its portfolio. Livforsakringsbolaget Skandia Omsesidigt owns 2,707 shares or 0.04% of their US portfolio. Bancorp Pictet & Cie (Asia) Ltd invested 0.39% in Marriott International, Inc. (NASDAQ:MAR). Virtu Financial Llc has 0% invested in Marriott International, Inc. (NASDAQ:MAR) for 2,814 shares. Norinchukin Bank The reported 37,042 shares. Castleark Mgmt Ltd Liability Corporation stated it has 0.01% in Marriott International, Inc. (NASDAQ:MAR). California Public Employees Retirement Systems invested in 0.1% or 606,549 shares. Piedmont Inv Advisors stated it has 0.24% in Marriott International, Inc. (NASDAQ:MAR).

Since July 20, 2018, it had 0 insider buys, and 2 sales for $1.92 million activity. SUSMAN SALLY had sold 40,381 shares worth $1.50M.

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It improved, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Dekabank Deutsche Girozentrale accumulated 1.85% or 7.52M shares. Evergreen Capital Mngmt Limited Liability Company reported 67,938 shares stake. Psagot Investment House Ltd holds 0.35% of its portfolio in Pfizer Inc. (NYSE:PFE) for 178,096 shares. Accuvest Advsrs, a California-based fund reported 24,024 shares. 1.15 million are owned by Scotia Cap Inc. Indiana Trust And Mngmt Co accumulated 0.44% or 21,840 shares. 143,410 are held by First National Communication. Moneta Gru Inv Advsr Ltd Liability Corp has 0.32% invested in Pfizer Inc. (NYSE:PFE). 2.23 million are owned by Zacks Inv Management. Advisor Llc has 158,905 shares. Pure Inc has invested 0.29% in Pfizer Inc. (NYSE:PFE). Round Table Ser Ltd Com stated it has 19,327 shares. Taylor Frigon Mgmt Limited Liability Corp reported 25,659 shares. Beck Mack Oliver Lc owns 96,628 shares. Wellington Shields And Lc has 55,468 shares.

Among 23 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Pfizer had 89 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Wednesday, August 16 by Jefferies. The firm has “Overweight” rating given on Friday, August 28 by Piper Jaffray. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by Jefferies on Thursday, October 13. JP Morgan reinitiated Pfizer Inc. (NYSE:PFE) on Thursday, April 7 with “Overweight” rating. The firm has “Neutral” rating by Credit Suisse given on Wednesday, August 1. The stock has “Buy” rating by Piper Jaffray on Friday, August 14. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Monday, August 14 by Cowen & Co. The stock of Pfizer Inc. (NYSE:PFE) has “Neutral” rating given on Wednesday, January 31 by Credit Suisse. On Tuesday, August 1 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Sell” rating given on Tuesday, November 6 by Citigroup.

Capital Advisors Inc, which manages about $1.68B US Long portfolio, upped its stake in Intel Corp (NASDAQ:INTC) by 158,976 shares to 225,552 shares, valued at $10.67M in 2018Q3, according to the filing. It also increased its holding in Lamar Advertising Co New (NASDAQ:LAMR) by 28,350 shares in the quarter, for a total of 213,046 shares, and has risen its stake in Virtu Finl Inc.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Fool.com which released: “3 Reasons Why Pfizer’s Latest Dividend Hike Is Better Than You Might Think – The Motley Fool” on December 18, 2018, also Streetinsider.com with their article: “Pfizer (PFE) Begins Phase 2b/3 Clinical Trial for PF-06651600 for Treatment of Patients with Moderate to Severe Alopecia Areata – StreetInsider.com” published on January 03, 2019, Seekingalpha.com published: “Pfizer to shutter two plants in India – Seeking Alpha” on January 09, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Streetinsider.com and their article: “Pfizer (PFE) Reports FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy – StreetInsider.com” published on January 14, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer, Merck cancel avelumab study – Seeking Alpha” with publication date: December 21, 2018.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.